Loading markets…

Ligand Pharmaceuticals Incorporated (LGND) forecast

Ligand Pharmaceuticals Incorporated (LGND) forecast: price $306.93, trailing P/E 31.45, forward P/E 32.84. How to read the street's path.

$306.93Price
$6.12BMarket cap
31.45P/E ?
32.84Forward P/E ?
0.00%Dividend yield ?

The live LGND price is $306.93. Trailing P/E is 31.45 and forward P/E is 32.84. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the LGND forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full LGND quote · Dividends · Price prediction · Academy

Questions

What is LGND's forward P/E?

The latest forward P/E on Stocklytics is 32.84, against a trailing P/E of 31.45 and a price of $306.93.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.